Stock listing
NYSE:MANE Veradermics, Incorporated Stock
Home listing (NYSE) of Veradermics, Incorporated
Follow Veradermics, Incorporated into a list and get an email when it puts out news.
Share price · NYSE:MANE
$139.69 USD -4.16 (-2.9%)
Close on Oct 30, 2026
- Day range
- $138.33 – $145.41 USDOct 30, 2026
- Volume
- 464,764 sharesOct 30, 2026
- Market cap
- $5.84B USDAt the close on Oct 30, 2026 · price × 41.78M shares outstanding
- Traded on an average day
- $89.33M USDMedian day 644,300 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:MANE · Home | $139.69 USD | -4.16 (-2.9%) | 464,764 | $141.79 | $145.41 | $138.33 | $143.85 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NYSE:MANE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $139.69 | -4.16 | -2.9% | $141.79 | $145.41 | $138.33 | 464,764 | |
| $143.85 | +0.02 | 0.0% | $141.96 | $146.58 | $140.19 | 513,422 | |
| $143.83 | +3.11 | +2.2% | $139.17 | $144.26 | $137.68 | 397,213 | |
| $140.72 | +3.33 | +2.4% | $136.84 | $141.08 | $136.76 | 466,648 | |
| $137.39 | -1.39 | -1.0% | $136.74 | $140.80 | $136.67 | 392,381 | |
| $138.78 | +0.29 | +0.2% | $139.44 | $139.93 | $134.49 | 423,100 | |
| $138.49 | +1.83 | +1.3% | $136.00 | $141.75 | $135.14 | 794,100 | |
| $136.66 | +9.55 | +7.5% | $127.50 | $139.12 | $127.14 | 706,900 | |
| $127.11 | +4.83 | +3.9% | $120.62 | $130.11 | $113.52 | 1,068,700 | |
| $122.28 | +13.46 | +12.4% | $115.34 | $123.93 | $113.00 | 1,463,900 | |
| $108.82 | -6.25 | -5.4% | $114.19 | $114.25 | $106.51 | 672,900 | |
| $115.07 | +1.60 | +1.4% | $112.74 | $115.99 | $111.05 | 688,900 | |
| $113.47 | -2.79 | -2.4% | $115.35 | $118.91 | $112.62 | 484,600 | |
| $116.26 | -6.14 | -5.0% | $121.17 | $122.27 | $115.67 | 845,100 | |
| $122.40 | -8.50 | -6.5% | $129.99 | $129.99 | $120.57 | 991,400 | |
| $130.90 | +4.27 | +3.4% | $125.71 | $135.12 | $123.02 | 1,113,900 | |
| $126.63 | +15.68 | +14.1% | $111.60 | $136.72 | $110.56 | 3,489,900 | |
| $110.95 | +1.99 | +1.8% | $108.92 | $113.43 | $108.84 | 655,100 | |
| $108.96 | -9.91 | -8.3% | $119.29 | $119.29 | $108.77 | 736,723 | |
| $118.87 | +2.11 | +1.8% | $116.45 | $119.12 | $114.80 | 536,363 | |
| $116.76 | -0.46 | -0.4% | $120.26 | $120.85 | $115.48 | 598,300 | |
| $117.22 | -4.01 | -3.3% | $121.23 | $123.83 | $116.04 | 659,800 | |
| $121.23 | +3.41 | +2.9% | $117.56 | $122.44 | $116.76 | 689,400 | |
| $117.82 | +2.82 | +2.5% | $115.34 | $118.94 | $112.03 | 481,700 | |
| $115.00 | -1.57 | -1.3% | $114.57 | $118.00 | $112.30 | 633,500 | |
| $116.57 | +0.85 | +0.7% | $116.00 | $118.15 | $113.88 | 613,600 | |
| $115.72 | -0.06 | -0.1% | $115.29 | $117.91 | $111.51 | 580,700 | |
| $115.78 | -2.36 | -2.0% | $118.11 | $118.74 | $110.60 | 753,800 | |
| $118.14 | +5.34 | +4.7% | $113.99 | $122.00 | $113.22 | 2,135,900 | |
| $112.80 | +6.05 | +5.7% | $107.44 | $113.24 | $105.40 | 583,600 | |
| $106.75 | -1.93 | -1.8% | $109.30 | $109.30 | $104.54 | 1,870,200 | |
| $108.68 | +6.26 | +6.1% | $105.56 | $109.74 | $102.83 | 766,500 | |
| $102.42 | -1.47 | -1.4% | $103.86 | $104.93 | $100.50 | 860,200 | |
| $103.89 | +2.19 | +2.2% | $102.02 | $105.26 | $100.01 | 938,800 | |
| $101.70 | +2.73 | +2.8% | $99.31 | $104.19 | $98.46 | 620,700 | |
| $98.97 | +0.83 | +0.8% | $99.45 | $102.29 | $98.82 | 576,000 | |
| $98.14 | -1.53 | -1.5% | $98.96 | $99.86 | $97.04 | 394,400 | |
| $99.67 | -4.16 | -4.0% | $103.20 | $104.53 | $97.00 | 552,600 | |
| $103.83 | +5.32 | +5.4% | $99.00 | $104.23 | $98.17 | 712,800 | |
| $98.51 | +0.76 | +0.8% | $98.92 | $99.89 | $97.20 | 363,000 | |
| $97.75 | -0.71 | -0.7% | $99.74 | $100.98 | $95.42 | 356,200 | |
| $98.46 | +0.95 | +1.0% | $97.80 | $100.55 | $95.44 | 427,200 | |
| $97.51 | -0.90 | -0.9% | $98.59 | $100.86 | $97.27 | 548,300 | |
| $98.41 | +0.48 | +0.5% | $100.00 | $101.38 | $97.14 | 678,500 | |
| $97.93 | -3.88 | -3.8% | $102.30 | $102.41 | $97.00 | 623,500 | |
| $101.81 | -0.99 | -1.0% | $102.06 | $103.44 | $100.39 | 270,800 | |
| $102.80 | +0.45 | +0.4% | $102.04 | $104.87 | $101.30 | 657,000 | |
| $102.35 | +3.89 | +4.0% | $100.31 | $104.08 | $97.73 | 787,163 | |
| $98.46 | -4.36 | -4.2% | $100.00 | $102.75 | $93.81 | 717,278 | |
| $102.82 | -2.50 | -2.4% | $105.18 | $108.87 | $102.52 | 393,600 | |
| $105.32 | -5.91 | -5.3% | $111.00 | $111.39 | $101.69 | 773,100 | |
| $111.23 | -0.08 | -0.1% | $114.50 | $117.40 | $110.07 | 748,300 | |
| $111.31 | +3.09 | +2.9% | $106.40 | $111.57 | $106.40 | 464,100 | |
| $108.22 | -4.49 | -4.0% | $111.28 | $111.28 | $106.08 | 581,700 | |
| $112.71 | +1.71 | +1.5% | $110.28 | $113.52 | $109.84 | 523,400 | |
| $111.00 | +1.95 | +1.8% | $108.75 | $111.98 | $107.37 | 571,700 | |
| $109.05 | +0.10 | +0.1% | $108.23 | $111.86 | $104.98 | 1,359,700 | |
| $108.95 | -1.80 | -1.6% | $109.67 | $110.47 | $106.78 | 561,902 | |
| $110.75 | -3.64 | -3.2% | $112.75 | $113.91 | $107.67 | 605,060 | |
| $114.39 | +5.74 | +5.3% | $110.68 | $114.41 | $109.80 | 542,200 | |
| $108.65 | -2.69 | -2.4% | $111.00 | $111.91 | $107.39 | 457,100 | |
| $111.34 | +4.06 | +3.8% | $108.62 | $114.30 | $107.68 | 936,200 | |
| $107.28 | +5.39 | +5.3% | $102.93 | $107.82 | $98.56 | 1,702,700 | |
| $101.89 | -3.11 | -3.0% | $102.15 | $105.00 | $93.77 | 2,765,500 | |
| $105.00 | +0.37 | +0.4% | $103.47 | $107.64 | $101.74 | 918,400 | |
| $104.63 | -3.13 | -2.9% | $106.45 | $111.07 | $104.25 | 684,300 |
- Ticker
- NYSE:MANE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NYSE
- Currency
- USD
What changed lately
Latest news release · Oct 19, 2026
Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 3 ‘304’ Clinical Trial in Male Pattern Hair Loss
Latest deck · Oct 19, 2026
Corporate Update (October 2026)
Corporate update · 50 slides
Latest news
Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 3 ‘304’ Clinical Trial in Male Pattern Hair Loss
Oct 19, 2026
Closed $122.28 (+12.4%) on Oct 19, 2026
Veradermics to Hold Conference Call to Discuss Topline Results from Phase 3 ‘304’ Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
Oct 18, 2026
Closed $122.28 (+12.4%) on Oct 19, 2026
Veradermics to Present at Upcoming September Investor Conferences
Sep 3, 2026
Closed $98.51 (+0.8%) on Sep 4, 2026
Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Aug 11, 2026
Closed $108.95 (-1.6%) on Aug 11, 2026
Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study ‘302’ in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy
Jul 17, 2026
Closed $111.32 (+5.2%) on Jul 17, 2026
Veradermics’ Oral VDPHL01 Delivers Positive Study ‘207’ Phase 2 Clinical Trial Results in Female Pattern Hair Loss Ahead of Upcoming Phase 2/3 Study ‘306’ Readout
Jul 15, 2026
Closed $123.70 (+12.3%) on Jul 15, 2026
Veradermics to Hold Conference Call to Discuss Study ‘207’ Phase 2 Clinical Trial Results of VDPHL01 in Females with Mild-to-Moderate Pattern Hair Loss
Jul 14, 2026
Closed $123.70 (+12.3%) on Jul 15, 2026
Veradermics to Present at Upcoming June Investor Conferences
May 28, 2026
Closed $100.91 (-1.9%) on May 29, 2026
Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 at the 2026 World Congress for Hair Research
May 27, 2026
Closed $100.13 (-2.3%) on May 27, 2026
Veradermics Announces Two Poster Presentations on VDPHL01 at the 2026 Music City SCALE Symposium
May 14, 2026
Closed $106.07 (-1.0%) on May 14, 2026
Decks
Corporate Update (October 2026)
Corporate update · 50 slides · Oct 19, 2026
Investor Presentation (September 2026)
Investor deck · 69 slides · September 2026
Technical Presentation (July 2026)
Technical · 41 slides · Jul 15, 2026
Technical Presentation (July 2026)
Technical · 41 slides · July 2026
Veradermics, Incorporated on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 21 in the last 12 months · 21 in all · newest Oct 19, 2026 · oldest 2026
- Decks
- 6 decks · latest Oct 19, 2026
Where Veradermics, Incorporated is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:MANE · Home listing · This page | NYSE | United States | USD |
| BX Swiss:MANE | BX Swiss | Switzerland | CHF |
| BOATS:MANE | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Veradermics, Incorporated.